Clincosm LogoSign in Get a demo

refractory solid tumors

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

Recruiting
  • Refractory Solid Tumors
  • Relapsed Solid Tumors
  • KSX01-TCRT cell therapy
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023

Precision Medicine Treatment for Refractory Solid Tumors

Recruiting
  • Refractory Solid Tumors
  • Next Generation Sequencing
    • Tianjin, Tianjin, China
      Tianjin Medical University Second Hospital
    Sep 2, 2023

    Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

    Recruiting
    • Refractory Solid Tumors
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 22, 2023

    TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSX01-TCRT injection)

    Recruiting
    • TCR-T Cells
    • +2 more
    • KSX01-TCRT injection
    • Nanning, Guangxi Zhuang Autonomous Region, China
      The first affiliated hospital of Guang Xi medical university
    Mar 31, 2023

    TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors Trial in Nanning (KSH01 injection)

    Recruiting
    • TCR-T Cells
    • +2 more
    • KSH01 injection
    • Nanning, Guang XI, China
      The first affiliated hospital of Guang Xi medical university
    Sep 14, 2022

    Refractory Solid Tumors Trial in Seoul (sirolimus)

    Completed
    • Refractory Solid Tumors
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Refractory Solid Tumors Trial in Seoul (pazopanib)

    Completed
    • Refractory Solid Tumors
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Refractory Solid Tumors Trial in Seoul (sunitinib)

    Completed
    • Refractory Solid Tumors
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Refractory Solid Tumors Trial in Seoul (pazopanib)

    Completed
    • Refractory Solid Tumors
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Refractory Solid Tumors Trial in Seoul (Sunitinib)

    Completed
    • Refractory Solid Tumors
    • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Relapsed Solid Tumors, Refractory Solid Tumors, Relapsed Leukemia Trial in Canada, United States (Carfilzomib, Cyclophosphamide,

    Recruiting
    • Relapsed Solid Tumors
    • +3 more
    • Phoenix, Arizona
    • +7 more
    Apr 12, 2022

    Relapsed Solid Tumors, Refractory Solid Tumors Trial in Aurora, Lexington, Dallas (Eribulin, Irinotecan, Cefixime)

    Completed
    • Relapsed Solid Tumors
    • Refractory Solid Tumors
    • Aurora, Colorado
    • +2 more
    Jan 31, 2022

    Solid Tumor, Cancer, Recurrent Solid Tumors Trial in Germany, United States (IMA201 Product, IMADetect®)

    Recruiting
    • Solid Tumor
    • +3 more
    • IMA201 Product
    • IMADetect®
    • Chicago, Illinois
    • +6 more
    Dec 28, 2021

    Refractory Solid Tumors Trial in Kogarah (BNA035)

    Not yet recruiting
    • Refractory Solid Tumors
    • Kogarah, New South Wales, Australia
      St George Private Hospital
    Dec 3, 2021

    Refractory Solid Tumors Trial in Taichung, Tainan (Nanoliposomal Irinotecan)

    Active, not recruiting
    • Refractory Solid Tumors
    • Nanoliposomal Irinotecan
    • Taichung, Taiwan
    • +1 more
    Sep 16, 2021

    Refractory Solid Tumors Trial in Shanghai (Arsenic trioxide)

    Recruiting
    • Refractory Solid Tumors
    • Arsenic trioxide
    • Shanghai, China
      Department of Oncology, Ruijin Hospital
    May 11, 2021

    Cancer, Tumors, Tumors Trial in Dallas, Seattle (IT-141)

    Terminated
    • Cancer
    • +4 more
    • Dallas, Texas
    • +1 more
    Dec 18, 2020

    Advanced Relapsed Tumors, Refractory Solid Tumors Trial in United States (OMP-131R10, FOLFIRI)

    Completed
    • Advanced Relapsed Tumors
    • Refractory Solid Tumors
    • San Francisco, California
    • +6 more
    Aug 10, 2020

    Refractory Solid Tumors, Melanoma Trial in Israel, United States (IMO-2125)

    Completed
    • Refractory Solid Tumors
    • Melanoma
    • Scottsdale, Arizona
    • +11 more
    Feb 10, 2020

    Refractory Solid Tumors Trial in Seoul (Sorafenib)

    Withdrawn
    • Refractory Solid Tumors
    • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
      Samsung Medical Center
    Dec 26, 2019

    Lymphoma, Refractory Solid Tumors, Advanced Cancer Trial in United States (ASP4132)

    Completed
    • Lymphoma
    • +2 more
    • New Haven, Connecticut
    • +4 more
    May 31, 2019

    Refractory Solid Tumors Trial in Seoul (sorafenib)

    Completed
    • Refractory Solid Tumors
    • Seoul, seoul, korea, Republic of, Korea, Republic of
      Samsung Medical Center
    Mar 10, 2017

    Refractory Solid Tumors, Lymphoma Trial in Nashville (Terameprocol (EM-1421))

    Terminated
    • Refractory Solid Tumors
    • Lymphoma
    • Terameprocol (EM-1421)
    • Nashville, Tennessee
      The Sarah Cannon Cancer Center
    Feb 20, 2016

    Refractory Solid Tumors, Pancreatic Adenocarcinoma Trial in Chapel Hill, Durham, Winston-Salem (gemcitabine, dasatinib)

    Terminated
    • Refractory Solid Tumors
    • Pancreatic Adenocarcinoma
    • Chapel Hill, North Carolina
    • +2 more
    Sep 4, 2015

    Refractory Solid Tumors, Lymphomas Trial in Tacoma (Lenvatinib, Moxifloxacin 400 mg, Placebos (matched to 4 mg and 10 mg

    Completed
    • Refractory Solid Tumors
    • Lymphomas
    • Tacoma, Washington
      Charles River
    Mar 3, 2015